Affimed NV (AFMD)
5.31
-0.13
(-2.39%)
USD |
NASDAQ |
May 17, 16:00
5.31
0.00 (0.00%)
After-Hours: 19:46
Affimed Revenue (Quarterly): 0.4448M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.4448M |
| September 30, 2023 | 2.136M |
| June 30, 2023 | 1.516M |
| March 31, 2023 | 4.844M |
| December 31, 2022 | 11.41M |
| September 30, 2022 | 15.00M |
| June 30, 2022 | 7.777M |
| March 31, 2022 | 8.984M |
| December 31, 2021 | 11.82M |
| September 30, 2021 | 10.21M |
| June 30, 2021 | 11.70M |
| March 31, 2021 | 14.05M |
| December 31, 2020 | 11.62M |
| September 30, 2020 | 12.33M |
| June 30, 2020 | 3.231M |
| March 31, 2020 | 5.667M |
| December 31, 2019 | 4.348M |
| September 30, 2019 | 2.338M |
| June 30, 2019 | 4.503M |
| March 31, 2019 | 12.90M |
| December 31, 2018 | 25.95M |
| September 30, 2018 | 0.3558M |
| Date | Value |
|---|---|
| June 30, 2018 | 0.1791M |
| March 31, 2018 | 0.6536M |
| December 31, 2017 | 0.749M |
| September 30, 2017 | 0.549M |
| June 30, 2017 | 0.5589M |
| March 31, 2017 | 0.425M |
| December 31, 2016 | 1.479M |
| September 30, 2016 | 1.047M |
| June 30, 2016 | 2.338M |
| March 31, 2016 | 2.136M |
| December 31, 2015 | 1.815M |
| September 30, 2015 | 1.284M |
| June 30, 2015 | 2.442M |
| March 31, 2015 | 2.864M |
| December 31, 2014 | 0.1012M |
| September 30, 2014 | 2.507M |
| June 30, 2014 | 0.9423M |
| March 31, 2014 | 0.9891M |
| December 31, 2013 | 6.296M |
| September 30, 2013 | 0.2532M |
| June 30, 2013 | 0.2625M |
| March 31, 2013 | 0.0924M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.4448M
Minimum
Dec 2023
15.00M
Maximum
Sep 2022
7.575M
Average
7.777M
Median
Jun 2022
Revenue (Quarterly) Benchmarks
| InflaRx NV | 0.0391M |
| MorphoSys AG | 63.62M |
| BioNTech SE | 203.77M |
| Immatics NV | 32.88M |
| CureVac NV | 24.30M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -21.76M |
| Total Expenses (Quarterly) | 26.50M |
| EPS Diluted (Quarterly) | -1.497 |
| Enterprise Value | 15.69M |
| Profit Margin (Quarterly) | -4.89K% |
| Earnings Yield | -144.5% |
| Normalized Earnings Yield | -146.65 |